Recently, Sun and colleagues [15] have shown that a MEK inhibitor as a single agent was ineffective in inhibiting tumor growth in colorectal and lung cancer models, which they observed to be correlated with transcriptional induction of ERBB3. The gene discussed is MAP2K7; the disease is neoplasm.